James Edgemond's Net Worth
James Edgemond's net worth is estimated to be at least $65,237,154.05 as of 04/22/2026. CoreStreet's estimation of James Edgemond's net worth is based on their sale of stock and current holding of stock.
James Edgemond is CFO at United Therapeutics Corporation. They have executed at least 16 trades of stock as per SEC Form 4 filings. Their most recent trade was for 10,000 units of UTHR stock on 04/16/2026. Their biggest sale was on 04/09/2026 when they sold 10,000 units of United Therapeutics Corporation stock for $5,778,900.00. They typically trade 5 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $65,237,154.05
Most recent insider trade:
- April 16, 2026
James Edgemond's Insider Trading History
| United Therapeutics Corporation | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 16, 2026 | CFO | 10,000 | $577.18 | Sell | $5,771,800.00 |
April 13, 2026 | CFO | 10,000 | $574.88 | Sell | $5,748,800.00 |
April 9, 2026 | CFO | 10,000 | $577.89 | Sell | $5,778,900.00 |
April 6, 2026 | CFO | 10,000 | $558.40 | Sell | $5,584,000.00 |
April 2, 2026 | CFO | 10,000 | $561.50 | Sell | $5,615,000.00 |
March 26, 2026 | CFO | 10,000 | $535.90 | Sell | $5,359,000.00 |
March 23, 2026 | CFO | 10,000 | $527.48 | Sell | $5,274,800.00 |
June 9, 2025 | CFO | 12,000 | $325.37 | Sell | $3,904,440.00 |
Oct. 28, 2024 | CFO | 7,800 | $350.00 | Sell | $2,730,000.00 |
Oct. 21, 2024 | CFO | 7,782 | $366.99 | Sell | $2,855,916.18 |
Oct. 14, 2024 | CFO | 7,792 | $355.88 | Sell | $2,773,016.96 |
Oct. 7, 2024 | CFO | 7,794 | $355.54 | Sell | $2,771,078.76 |
Sept. 30, 2024 | CFO | 7,792 | $358.62 | Sell | $2,794,367.04 |
Sept. 23, 2024 | CFO | 7,796 | $354.04 | Sell | $2,760,095.84 |
Sept. 9, 2024 | CFO | 7,802 | $345.41 | Sell | $2,694,888.82 |
Sept. 3, 2024 | CFO | 7,785 | $362.37 | Sell | $2,821,050.45 |